Clostridium difficile Infection: Emerging Therapies and Recurrence Prevention

VOORHEES, N.J., Dec. 20, 2011 /PRNewswire/ -- Rates of Clostridium difficile Infection (CDI) have been on the rise in recent years and this diagnosis can result in significant costs for both individuals and the healthcare system as a whole. Given the recent updated guidelines for CDI, combined with several new agents emerging for this disease, it is critical for healthcare professionals to be aware of the most current research and recommendations for the management of CDI.

To address the need for current education on CDI, RMEI, LLC and Postgraduate Institute for Medicine (PIM) are jointly sponsoring a complimentary continuing education virtual lecture titled Clostridium difficile Infection: Emerging Therapies and Recurrence Prevention which is certified for physicians, pharmacists and nurses. This activity is supported by an educational grant from Optimer.

Dale Gerding, MD, FACP, FIDSA, Professor of Medicine, Stritch School of Medicine at Loyola University Chicago, serves as moderator for this virtual lecture which was derived from a live symposium held in Boston, Massachusetts in October, 2011.

Healthcare professionals can visit www.rmei.com/cdi432vlnew to access this activity.

RMEI is a medical education company that specializes in independent, continuing medical education designed for clinicians to improve and deliver quality medical care to patients. The goal of RMEI educational offerings is to promote continuous professional development and the improvement of health outcomes. RMEI works closely with medical experts to develop activities that improve diagnosis and treatment leading to better outcomes for patients. These activities include national and international symposia, teleconferences, live meetings, enduring print materials, and interactive Internet programs.

For other educational opportunities, please visit www.RMEI.com.

SOURCE RMEI